SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,018,567 | -50.3% | 23,117,045 | 0.0% | 3.99% | -19.2% |
| Q2 2023 | $110,730,646 | -15.5% | 23,117,045 | 0.0% | 4.94% | -3.0% |
| Q1 2023 | $131,073,645 | +1.2% | 23,117,045 | 0.0% | 5.09% | +23.2% |
| Q4 2022 | $129,455,452 | -12.8% | 23,117,045 | 0.0% | 4.13% | -33.8% |
| Q3 2022 | $148,411,000 | +200.9% | 23,117,045 | +60.8% | 6.25% | +236.2% |
| Q2 2022 | $49,319,000 | -51.8% | 14,378,802 | 0.0% | 1.86% | -22.7% |
| Q1 2022 | $102,376,000 | -14.5% | 14,378,802 | 0.0% | 2.40% | +29.8% |
| Q4 2021 | $119,774,000 | +19.7% | 14,378,802 | 0.0% | 1.85% | +76.7% |
| Q3 2021 | $100,076,000 | -70.8% | 14,378,802 | 0.0% | 1.05% | -76.1% |
| Q2 2021 | $342,935,000 | +13.5% | 14,378,802 | -2.0% | 4.38% | -9.5% |
| Q1 2021 | $302,137,000 | -16.0% | 14,673,973 | 0.0% | 4.84% | -26.1% |
| Q4 2020 | $359,512,000 | -41.1% | 14,673,973 | -32.0% | 6.54% | -61.2% |
| Q3 2020 | $610,696,000 | +494.8% | 21,571,764 | 0.0% | 16.87% | +465.3% |
| Q2 2020 | $102,681,000 | +33.3% | 21,571,764 | 0.0% | 2.98% | -17.3% |
| Q1 2020 | $77,011,000 | +3.5% | 21,571,764 | 0.0% | 3.61% | -13.2% |
| Q4 2019 | $74,423,000 | -14.0% | 21,571,764 | 0.0% | 4.16% | -12.1% |
| Q3 2019 | $86,502,000 | +24.5% | 21,571,764 | 0.0% | 4.73% | +57.4% |
| Q2 2019 | $69,461,000 | -20.3% | 21,571,764 | +70.1% | 3.01% | -8.8% |
| Q1 2019 | $87,131,000 | +52.0% | 12,682,876 | 0.0% | 3.30% | +17.8% |
| Q4 2018 | $57,327,000 | -40.4% | 12,682,876 | 0.0% | 2.80% | -56.0% |
| Q3 2018 | $96,263,000 | -11.7% | 12,682,876 | 0.0% | 6.36% | -69.5% |
| Q2 2018 | $109,073,000 | +17.2% | 12,682,876 | 0.0% | 20.89% | -22.6% |
| Q1 2018 | $93,092,000 | -27.6% | 12,682,876 | 0.0% | 26.99% | -17.2% |
| Q4 2017 | $128,604,000 | -36.8% | 12,682,876 | 0.0% | 32.61% | -52.1% |
| Q3 2017 | $203,433,000 | +41.9% | 12,682,876 | 0.0% | 68.04% | +34.6% |
| Q2 2017 | $143,316,000 | +0.3% | 12,682,876 | 0.0% | 50.54% | +33.0% |
| Q1 2017 | $142,936,000 | +13.8% | 12,682,876 | 0.0% | 37.99% | -7.0% |
| Q4 2016 | $125,560,000 | -19.4% | 12,682,876 | 0.0% | 40.85% | -4.1% |
| Q3 2016 | $155,873,000 | – | 12,682,876 | – | 42.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |